$LRCX

TALWALKAR ABHIJIT Y sold $6.1M of LRCX

TALWALKAR ABHIJIT Y sold 18,282 shares of LAM RESEARCH CORP (LRCX) at $335.00 ($6.12M total) on 2026-07-13 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · TALWALKAR ABHIJIT Y
Published Jul 14, 2026, 4:56 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 14, 2026, 4:58 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LRCX
Neutral
high confidence
Mentioned
$LRCX
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LRCXNeutralLow
01

Why it matters

The newest fact is the director’s open-market sale of 18,282 shares at $335/share, totaling about $6.12M, executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may monitor for follow-on insider activity, but this specific disclosure alone does not introduce new operational or financial guidance.

03

What to watch

The filing does not state reasons for sale or any new company-specific information; any price reaction would likely be short-lived and sentiment-driven.

Relevance 5/10Novelty 3/10Timing: Filed 2026-07-14, transaction dated 2026-07-13.

Background

The article is an SEC Form 4 insider transaction disclosure for LAM Research Corp (LRCX).

Company-level read

Ticker impact

$LRCXNeutralHigh confidence
Context

Form 4 shows LRCX director Talwalkar sold 18,282 shares in an open-market transaction at $335/share on 2026-07-13 under a 10b5-1 plan.

Expected impact

Limited, likely sentiment-only impact; no clear directional fundamental catalyst from the filing alone.

Evidence & confidence

The filing is a routine Form 4 sale by a director, explicitly under a pre-arranged 10b5-1 plan, with no accompanying earnings, guidance, or operational change disclosed.

Market effects

No sector read-across; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity rather than bearish expectations, so traders may discount it.

Key entities

  • LRCX

    Lam Research Corp, issuer of the Form 4 insider sale.

  • TALWALKAR ABHIJIT Y

    Director who sold 18,282 shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BACMed

US Futures Hold Steady Ahead of Inflation Report

US stock futures were stable on Wednesday ahead of the September inflation report. Bank of America shares fell over 2% after $1.2B in penalties from regulators. Memory stocks declined due to AI investment concerns and Chinese competition, with Micron down 4.6%. Financial stocks also dropped post-earnings, including Citigroup (-5.3%) and Wells Fargo (-2.6%).

$LRCXLow

Round Design Infringement Case Against Lam Research < Supply Chain < 기사본문

BCNC, a South Korean semiconductor component maker, was ordered by a Seoul court to stop producing and distributing certain edge-ring products, pay damages, and destroy existing inventory, following a design-right infringement lawsuit by Lam Research. The court partially dismissed Lam Research's claims. Both companies are also involved in separate patent disputes, with mixed rulings. BCNC plans to appeal the decision.

$LRCXMedAI 8/10

Lam Research Stocks Fall 2.1% as AI Spending Lifts Target 33%

Lam Research (LRCX) shares fell 2.42% to $325.81 on October 7, despite Cantor Fitzgerald raising its price target to $425 from $320. The company reported June-quarter revenue of $6.72 billion, up 15.1% from the prior quarter, with improved margins. Cantor's target suggests 30.4% upside, but shares are 106.68% above GF Value™ estimate of $157.64.

$LRCXHigh

TSMC Stock Hits Record High, Morgan Stanley Raises Lam Research Price Target

TSMC (TSM) stock hit a record high, nearing a $2.5T market cap, driven by AI chip demand. Morgan Stanley raised Lam Research's (LRCX) price target to $385, citing its share gains in advanced logic and expected December-quarter revenue of $9B, above consensus. The bank sees LRCX as a key beneficiary of TSMC's 2nm process advancements and increased capital expenditure share.